Role of Thai Oncology Pharmacists in Lung Cancer Treatment: A Q&A With Dr. Suthan Chanthawong
Suthan Chanthawong, BPharm, BCP, BCOP, is an assistant professor of Pharmaceutical Sciences in the Division of Clinical Pharmacy at Khon Kaen University, in Thailand. In the following interview, he discusses […] Read more
PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity
Wei Xu, MD, PhDIn reference to: Mayoux M, Roller A, Pulko V, et al. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy. Sci Transl Med. 2020;12(534):eaav7431. Checkpoint blockade with PD-1 or PD-L1 […] Read more
Experts discuss how a global pandemic is putting pressure on traditional methods of research dissemination. A search on PubMed.gov for COVID-19 reveals 93,851 results as of Mid-January 2021. “To put […] Read more
Should We Delay Lung Cancer Screening During the COVID-19 Pandemic?
David Yankelevitz, MDTo address the issue of low-dose CT screening, during the COVID-19 pandemic, for lung cancer and management of both screen-detected nodules and incidentally detected nodules, various eminent organizations and expert […] Read more
Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey
Matthew P. Smeltzer, PhD+more
The past 10 years have seen a dramatic increase in novel therapeutic options for patients with lung cancer, with many treatments now personalized to the specific tumor characteristics of each […] Read more
Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604
Urania Dafni, ScD+more
In the era of targeted treatments and immunotherapies, it is relatively common to address multiple questions in a single phase III clinical trial. These questions often involve using more than […] Read more
Impactful Multidisciplinary Care Not Out of Reach in Community Settings
Leah LawrenceIn 2014 the IASLC, in collaboration with the American Thoracic Society and the European Respiratory Society, published a new classification of lung adenocarcinoma.1 The publication addressed new terminology and diagnostic […] Read more
Adjusting Occupational and Physical Therapy Services for Patients With Lung Cancer During the COVID-19 Pandemic
Pippa Labuc, BSc OT+more
The COVID-19 pandemic has had a significant impact on the role of therapy services for patients with a thoracic oncology diagnosis. Here we look at how two facilities, an occupational […] Read more
CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients With Lung Cancer
Soon Ho Yoon, MD, PhD+more
The COVID-19 pandemic has caused more than 43.2 million cumulative cases and 1.16 million deaths, as of late October 2020. Approximately 1% of patients with COVID-19 have malignancy,1 and lung […] Read more
EGFR/ALK-Mutated NSCLC: Using Real-world Therapeutic Practices to Help Answer Real-world Therapeutic Questions
Shirish Gadgeel, MDILCN Editorial Group member Shirish M. Gadgeel, MD, is Chief of the Division of Hematology/Oncology at the Henry Ford Cancer Institute/Henry Ford Hospital. Dr. Gadgeel is currently working, in conjunction […] Read more